Abstract
In 1981 Reitz and his co-workers at Stanford University successfully introduced heart—lung transplantation into clinical practice1, 2. Although the new form of transplantation was rapidly taken up by other centers, the pace of further development has been significantly slowed by the scarcity of suitable heart—lung donors. It was also soon appreciated that heart—lung recipients are at risk for a number of serious complications in the postoperative period, the most important of which are intrathoracic infections, particularly pneumonias3. These complications account for the fact that the healthy survival of heart—lung recipients is worse than other major organ transplant recipients3–5.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Reitz, B.A., Wallwork, J.L., Hunt, S.A., Pennock, J.L., Billingham, M.E., Oyer, P.E., Stinson, E.B. and Shumway, N.E. (1982). Heart—lung transplantation. Successful therapy for patients with pulmonary vascular disease. N. Engl. J. Med., 306, 557
Jamieson, S.W, Reitz, B.A., Oyer, P.E. et al. (1983). Combined heart and lung transplantation. Lancet, 1, 1130
Griffith, B.P. (1987). Cardiopulmonary transplantation — growing pains. Int. J. Cardiol., 17, 119
Morris, A.J.R. and Jamieson, S.W. (1987). Combined heart—lung transplantation for end-stage right ventricular failure. Cardiol. Clin., 17, 251
Thompson, M.E., Dummer, J.S., Paradis, I., Zeevi, A., Griffith, B.P. and Hardesty, R.L. (1987). Heart—lung transplantation — the courage to succeed. In Yu, P. (ed.) Progress in Cardiology. Vol. 16 (3). (Philadelphia: Lea and Febiger)
Pollard, R.B., Rand, K.H., Gamberg, P., Gallagher, J.G. and Merigan, T.C. (1982). Specific cell mediated immunity and infections with herpesvirus in cardiac transplant recipients. Am. J. Med., 73, 679
Luft, B.J., Naot, Y., Araujo, F.G., Stinson, E.B. and Remington, J.S. (1983). Primary and reactivated toxoplasma infection in patients with cardiac transplants. Ann. Intern. Med., 99, 27
Wreghitt, T.G., Hakim, M., Cory-Pearce, R., English, T.A.H. and Wallwork, J. (1986). The impact of donor-transmitted CMV and Toxomplasma gondii disease in cardiac transplantation. Transplant. Proc., 18, 1375
Siegelman, S.S., Sinha, S.B.P. and Veith, F.J. (1973). Pulmonary reimplantation response. Ann. Surg., 177, 30
Jamieson, S.W., Stinson, E.B., Oyer, P.E., Reitz, B.A., Baldwin, J., Modry, D., Dawkins, K., Theodore, J., Hunt, S. and Shumway, N.E (1984). Heart—lung transplantation for irreversible pulmonary hypertension. Ann. Thorac. Surg., 38, 554
Mancini, M.C., Borovetz, H.S., Griffith, B.P. and Hardesty, R.L. (1985). Changes in lung vascular permeability after heart—lung transplantation. J. Surg. Res., 39, 305
Dauber, J.H. and Zeevi, A. (1988). Lung transplantation: lessons learned about local immune function and pulmonary defense mechanisms. In Daniele, R.P. (ed.) Pulmonary Immunology, p. 625. (New York: McGraw Hill)
Mancini, M.C. and Tauxe, W.N. (1986). Assessment of pulmonary clearance in heart—lung transplant recipients using technetium99 minimicronized albumin colloid (MMAC). Am. Rev. Respir. Dis., 133, All
Paradis, I.L., Marrari, M., Zeevi, A., Duquesnoy, R.J., Griffith, B.P., Hardesty, R.L. and Dauber, J.H. (1985). HLA phenotype of lung lavage cells following heart—lung transplantation. J. Heart Transplant., 4, 422
Fung, J.J., Zeevi, A., Kaufman, C., Paradis, I.L., Dauber, J.H., Hardesty, R.L., Griffith, B. and Duquesnoy, R.J. (1985). Interactions between lymphocytes and macrophages in heart—lung transplant recipients. Human Immunol., 14, 287
Zeevi, A., Fung, J.J., Paradis, I.L., Dauber, J.H., Griffith, B.P, Hardesty, R.L. and Duquesnoy, R.J. (1985). Lymphocytes of bronchoalveolar lavage from heart—lung transplant recipients. J. Heart Transplant., 4, 417
Zeevi, A, Fung, J.J, Paradis, I.L, Gryzan, S, Dauber, J.H, Hardesty, R.L, Griffith, B, Trento, A, Saidman, S. and Duquesnoy, R.J. (1987). Bronchoalveolar macrophage—lymphocyte reactivity in heart—lung transplant recipients. Transplant. Proc., 19, 2537
Muggenburg, B.A, Bice, D.E, Haley, P.J, Mauderly, J.L, Dauber, J.J, Heron, K. and Griffith, B.P. (1987). Immune response in the transplanted canine lung. Am. Rev. Respir. Dis., 135, A103
Brooks, R.G, Hofflin, J.M, Jamieson, S.W, Stinson, E.B. and Remington, J.S. (1985). Infectious complications in heart—lung transplant recipients. Am. J. Med., 79, 412
Dummer, J.S, Montero, C.G, Griffith, B.P, Hardesty, R.L, Paradis, I.L. and Ho, M. (1986). Infections in heart—lung transplant recipients. Transplantation, 41, 725
Griffith, B.P, Kormos, R.L, Hardesty, R.L, Armitage, J.M. and Dummer, J.S. (1988). The artificial heart: infection-related morbidity and its effect on transplantation. Ann. Thorac. Surg., 45, 409
Ho, M. (1982). Cytomegalovirus: Biology and Infection. (New York: Plenum Press)
Dummer, J.S, White, L.T, Ho, M, Griffith, B.P, Hardesty, R.L. and Bahnson, H.T. (1985). Morbidity of cytomegalovirus infection in recipients of heart or heart—lung transplants who received cyclosporine. J. Infect. Dis., 152, 1182
Meyers, J.D, Flournoy, N. and Thomas, E.D. (1982). Nonbacterial pneumonia after allogeneic marrow transplantation: a review of ten years’ experience. Rev. Infect. Dis., 4, 1119
Shepp, D.H, Danliker, P.S, Miranda, P, Burnette, T.C, Cederberg, D.M, Kirk, L.E. and Meyers, J.D. (1985). Activity of 9-[2-hydroxyl-l-(hydroxymethyl) ethoxymethyl] guanine in the treatment of cytomegalovirus pneumonia. Ann. Intern. Med., 103, 368
Erice, A, Jordon, M.C, Chace, B.A, Fletcher, C, Chinnock, B.J. and Balfour, H.H. Jr. (1987). Ganciclovir treatment of cytomegalovirus disease in transplant recipients and other immunocompromised hosts. J. Am. Med. Assoc., 257, 3082
Syndman, D.R, Werner, B.G, Heinze-Lacey, B, Berardi, V.P, Tilney, N.L, Kirkman, R.L, Milford, E.L, Cho, S.I, Bush H.L. Jr., Levey, A.S, Strom, T.B, Carpenter, C.B, Levey, R.H, Harmon, W.E, Zimmerman, C.E, Shapiro, M.E, Steinman, T, Logerfo, F, Idelson, B., Schroter, G.P.J, Levin, M.J, McIves, J, Leszczyrski, J. and Grady, G.F. (1987). Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal transplant recipients. N. Engl. J. Med., 317, 1049
Ho, M, Miller, G, Atchison, R.W, Breinig, M.K, Dummer, J.S, Andeman, W, Starzl, T.E, Eastman, R, Griffith, B.P, Hardesty, R.L, Bahnson, H.T, Hakala, T.R. and Rosenthal, J.T. (1985). Epstein-Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: The role of primary infection. J. Infect. Dis., 152, 876
Beveridge, T, Krupp, P. and McKibbin, C. (1984). Lymphomas and lymphoproliferative lesions developing under cyclosporine therapy (Letter). Lancet, 1, 788
Hanto, D, Frizzera, G, Gajl-Peczalska, K. and Simmons, R. (1985). Epstein—Barr virus, immunodeficiency and B-cell lymphoproliferation. Transplantation, 39, 461
Starzl, T.E, Nalesnik, M.A., Porter, K.A, Ho, M, Iwatsuki, S, Griffith, B.P, Rosenthal, J.T, Hakala, T.R, Shaw, B.W. Jr., Hardesty, R.L. et al. (1984). Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporine-steroid therapy. Lancet, 1, 583
Allen, M.D, Burke, C.M, McGregor, C.G.A, Baldwin, J.C, Jamieson, S.W. and Theodore, J. (1986). Steroid-responsive bronchiolitis after human heart—lung transplantation. J. Thorac. Cardiovasc. Surg., 92, 449
Dummer, J.S, Bahnson, H.T, Griffith, B.P, Hardesty, R.L, Thompson, M.E. and Ho, M. (1983). Infections in patients on cyclosporine and prednisone following cardiac transplantation. Transplant. Proc., 15, 2779
Dummer, J.S, Ho, M, McMahon, D.K, Griffith, B.P, Hardesty, R.L, Trento, A. and Bahnson, H.T. (1987). Infectious complications in heart and heart—lung transplant recipients. Proceedings of the 1st European Conference on Transplantation, Venice, Italy, March 1987
Steffenson, D.O., Dummer, J.S, Granick, M.S., Pasculle, A.W, Griffith, B.P. and Cassell, G.H. (1987). Sternotomy infections with Mycoplasma hominis. Ann. Intern. Med., 106, 204
Bygdeman, S.M. and Mardh, P.A. (1984). Antimicrobial susceptibility and susceptibility testing of Mycoplasma hominis. Sex. Trans. Dis., 11, 366
Kenny, T, Hooten, M. and Roberts, M.C. (1987). Sensitivities of Mycoplasma hominis and Ureaplasma urealyticum to quinolones. Abstracts of the International Conference on Antimicrobial Agents and Chemotherapy, New York
Griffith, B.P, Hardesty, R.L, Trento, A. and Bahnson, H.T. (1985). Asynchronous rejection of heart and lungs following cardiopulmonary transplantation. Ann. Thorac. Surg., 40, 488
Griffith, B.P, Durham, S.J, Hardesty, R.L, Trento, A. and Paradis, I.L. (1987). Acute rejection of the heart—lung allograft and methods of its detection. Transplant. Proc., 19, 2527
Novitzky, D, Cooper, D.K.C, Wicomb, W.N, Rose, A.G. and Reichart, R. (1985). Transplantation of the heart and both lungs. S. Afr. Med. J., 67, 575
Yousem, S.A., Burke, C.M. and Billingham, M.E. (1985). Pathologic pulmonary alterations in long-term human heart—lung transplantation. Hum. Pathol, 16, 911
Theodore, J, Jamieson, S.W, Burke, C.M, Reitz, B.A, Stinson, E.B, Van Kessel, A, Dawkins, K.D, Herran, J.J, Oyer, P.E, Hunt, S.A., Shumway, N.E. and Robin, E.D. (1984). Physiologic aspects of human heart—lung transplantation. Chest, 86, 349
Burke, C.M, Theodore, J, Dawkins, K.D, Yousem, S.A., Blank, N, Billingham, M.E, Van Kessel, A, Jamieson, S.W, Oyer, P.E, Baldwin, J.C, Stinson, E.B, Shumway, N.E. and Robin, E.D. (1984). Post-transplant obliterative bronchiolitis and other late lung sequelae in human heart—lung transplantation. Chest, 86, 824
Gryzan, S, Paradis, I.L, Zeevi, A. et al. (1988). Unexpectedly high incidence of Pneumocystis carinii infection after lung—heart transplantation: implications for lung defense and allograft survival. Am. Rev. Respir. Dis., 137, 1268
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Kluwer Academic Publishers
About this chapter
Cite this chapter
Dummer, J.S. (1990). Infectious Complications. In: Cooper, D.K.C., Novitzky, D. (eds) The Transplantation and Replacement of Thoracic Organs. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-0711-9_41
Download citation
DOI: https://doi.org/10.1007/978-94-009-0711-9_41
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-6805-5
Online ISBN: 978-94-009-0711-9
eBook Packages: Springer Book Archive